Home › Acute Lymphocytic Leukemia › Washington › Seattle
Acute Lymphocytic Leukemia clinical trials in Seattle, WA
3 studies for Acute Lymphocytic Leukemia are looking for participants at sites in and around Seattle (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
211At-BC8-B10 Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Acute Leukemia or Myelodysplastic Syndrome
RecruitingPhase 1/2
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Outcomes in Pediatric and Young Adult B-Cell Malignancies After Commercially Available Immunotherapy
RecruitingObservational study
- Seattle Children's Hospital, Seattle
Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant Patients With Acute Leukemia or Myelodysplastic Syndrome (MDS)
RecruitingPhase 2
- Fred Hutch/University of Washington Cancer Consortium, Seattle
About Acute Lymphocytic Leukemia
Acute Lymphocytic Leukemia (ALL) or Acute Lymphoblastic Leukemia is a cancer of the white blood cells. Learn more about symptoms and treatment.
More about Acute Lymphocytic Leukemia on MedlinePlus
Other studies in Seattle
- Non-Small Cell Lung Cancer53 studies
- Cancer (all types)49 studies
- Prostate Cancer42 studies
- Acute Myeloid Leukemia40 studies
- Breast Cancer39 studies
- Metastatic Cancer39 studies
- Colorectal Cancer34 studies
- Lung Cancer33 studies
- Ovarian Cancer30 studies
- Multiple Myeloma22 studies
- Myelodysplastic Syndromes21 studies
- Acute Lymphoblastic Leukemia21 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.